Profound Medical & TULSA PRO®

Profound Medical is a leading medical technology company, specializing in developing and commercializing practical, minimally invasive treatments to improve patient's lives.
One of the company's hallmark innovations is the TULSA Procedure, an acronym for Transurethral Ultrasound Ablation. The TULSA Procedure is a groundbreaking treatment option for prostate cancer, designed to be minimally invasive and tailored to the individual needs of each patient.

The TULSA procedure is undertaken within a Magnetic Resonance Imaging (MRI) suite and utilizes the TULSA-PRO® system for the ablation of prostate tissue. The technique amalgamates real-time MRI and robotically-aided directional thermal ultrasound, ensuring precise, medically-prescribed ablation of either whole-gland or partial prostate tissue.